163 related articles for article (PubMed ID: 26883013)
1. Long-term costs of colorectal cancer treatment in Spain.
Corral J; Castells X; Molins E; Chiarello P; Borras JM; Cots F
BMC Health Serv Res; 2016 Feb; 16():56. PubMed ID: 26883013
[TBL] [Abstract][Full Text] [Related]
2. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
Brown ML; Riley GF; Potosky AL; Etzioni RD
Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
[TBL] [Abstract][Full Text] [Related]
3. [Estimation of hospital costs of colorectal cancer in Catalonia (Spain)].
Corral J; Borràs JM; Chiarello P; García-Alzorriz E; Macià F; Reig A; Mateu de Antonio J; Castells X; Cots F
Gac Sanit; 2015; 29(6):437-44. PubMed ID: 26318723
[TBL] [Abstract][Full Text] [Related]
4. Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain).
Corral J; Espinàs JA; Cots F; Pareja L; Solà J; Font R; Borràs JM
BMC Health Serv Res; 2015 Feb; 15():70. PubMed ID: 25889153
[TBL] [Abstract][Full Text] [Related]
5. Direct medical cost associated with colorectal cancer in north of Jordan.
Alefan Q; Malhees R; Mhaidat N
Curr Probl Cancer; 2017; 41(5):371-381. PubMed ID: 28629637
[TBL] [Abstract][Full Text] [Related]
6. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization.
Chastek B; Kulakodlu M; Valluri S; Seal B
Postgrad Med; 2013 Mar; 125(2):73-82. PubMed ID: 23816773
[TBL] [Abstract][Full Text] [Related]
7. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
Lang K; Lines LM; Lee DW; Korn JR; Earle CC; Menzin J
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):198-204. PubMed ID: 18849013
[TBL] [Abstract][Full Text] [Related]
8. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
[TBL] [Abstract][Full Text] [Related]
9. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
Delcò F; Egger R; Bauerfeind P; Beglinger C
Aliment Pharmacol Ther; 2005 Mar; 21(5):615-22. PubMed ID: 15740546
[TBL] [Abstract][Full Text] [Related]
10. Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach.
Joranger P; Nesbakken A; Sorbye H; Hoff G; Oshaug A; Aas E
Eur J Health Econ; 2020 Apr; 21(3):321-334. PubMed ID: 31707584
[TBL] [Abstract][Full Text] [Related]
11. Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysis.
Lang K; Lines LM; Lee DW; Korn JR; Earle CC; Menzin J
BMC Health Serv Res; 2009 Dec; 9():227. PubMed ID: 20003294
[TBL] [Abstract][Full Text] [Related]
12. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
[TBL] [Abstract][Full Text] [Related]
13. Modeling and validating the cost and clinical pathway of colorectal cancer.
Joranger P; Nesbakken A; Hoff G; Sorbye H; Oshaug A; Aas E
Med Decis Making; 2015 Feb; 35(2):255-65. PubMed ID: 25073464
[TBL] [Abstract][Full Text] [Related]
14. Cost Analysis of Free Colonoscopies in an Uninsured Population at Increased Risk for Colorectal Cancer.
Sutton ER; Walling S; Kimbrough C; Borkhetaria N; Jones W; Sutton B
J Am Coll Surg; 2016 Jul; 223(1):129-32. PubMed ID: 27238000
[TBL] [Abstract][Full Text] [Related]
15. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
Etzioni R; Ramsey SD; Berry K; Brown M
Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
[TBL] [Abstract][Full Text] [Related]
16. An incidence model of the cost of advanced prostate cancer in Spain.
Hart WM; Nazir J; Baskin-Bey E
J Med Econ; 2014 Feb; 17(2):125-31. PubMed ID: 24350997
[TBL] [Abstract][Full Text] [Related]
17. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
18. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
Ramsey SD; Berry K; Etzioni R
Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
[TBL] [Abstract][Full Text] [Related]
19. Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia.
Goldsbury DE; Feletto E; Weber MF; Haywood P; Pearce A; Lew JB; Worthington J; He E; Steinberg J; O'Connell DL; Canfell K
PLoS One; 2021; 16(11):e0260088. PubMed ID: 34843520
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a carcinoembryonic antigen (CEA) based follow-up programme for colorectal cancer (the CEA Watch trial).
Verberne CJ; Wiggers T; Grossmann I; de Bock GH; Vermeulen KM
Colorectal Dis; 2016 Mar; 18(3):O91-6. PubMed ID: 26757353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
